ABOUT THE EVENT
Date: Sunday, September 21, 2025 8am–6:15pm PDT
Event Location: San Francisco , California
hubXchange invites you to the Antibody Therapeutics Xchange – San Francisco 2025, an exclusive, highly interactive event that unites senior-level scientists and executives from leading pharmaceutical and biotech organizations. This one-day forum will address cutting-edge innovations and real-world challenges across the full spectrum of antibody drug development.
What to Expect
7 Scientific Tracks:
Target Selection & Mechanisms of Action
Lead Identification & Optimization
Formats & Scaffolds
Bi/Multispecifics
AI & Machine Learning
ADC Linker Design & Conjugation Technologies
ADC Cytotoxic Payload
Session Formats:
Roundtable Discussions
Keynote & Spotlight Presentations
Poster Presentations
Pre-booked 1-2-1 Partnering Meetings
Networking Breaks & Drinks Reception
Agenda Highlights
Keynote Speakers Include:
Pavel Ryzhov, Sr. Business Development Manager – WuXi Biologics
Jordon Wang, Chief Operating Officer – AvantGen
Alon Wellner, VP Biology & Co-Founder – Aureka Bio
Roundtable Highlights:
Danielle Dettling (Fury Biosciences): Using existing targets for effective therapeutics
Anthony Maida (Oncotelic Therapeutics): Managing immune-related toxicities in bispecifics
Sayantan Mitra (BigHat Biosciences): AI/ML-assisted antibody engineering – hype or revolution?
Sachin Shivatare (Eli Lilly): Optimizing ADC linkers for specificity and payload efficacy
Poster Highlights:
Bio-Rad: Rapid Lead Generation with the Pioneer Antibody Discovery Platform
Evitria: Solving the bispecific antibody mispairing challenge
GenScript: TurboCHO for next-gen BsAb manufacturing
Why Attend?
Participate in deep-dive discussions with scientific peers
Discover emerging trends and technologies in antibody drug development
Build meaningful 1:1 partnerships through curated networking
Gain exclusive insights from industry pioneers
